Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ravenquest Biomed Inc RVVQF

Ravenquest BioMed Inc is a Canada-based diversified cannabis company with divisions focused upon cannabis production, management services and consulting and specialized research and development. It provides integrated solutions to companies in the cannabis industry and provides growing and drying technologies, patient and genetic management systems, and security management solutions The company operates through the following segments - Consulting business and Cultivation and Sale of Medical Cannabis.


GREY:RVVQF - Post by User

Post by lscfaon Oct 10, 2019 11:35pm
290 Views
Post# 30220411

Reduced holding by money manager

Reduced holding by money manager
Since the last report filed on July 10, 2019, MM Asset, on behalf of MMCAP, has disposed of an aggregate 99,000 March Warrants (as described in Item 3.2 below) and 2,898,500 Shares, representing a net decrease of approximately 2.36% of the Issuer’s 123,913,559 outstanding Shares as reported by the Issuer in its Management Discussion and Analysis dated September 30, 2019 (the “Outstanding Shares”), calculated on a partially diluted basis.
 
As at the end of September 2019, MM Asset, on behalf of MMCAP, exercised control and direction over:
(i) 4,000,000 Shares;
 
(ii) 10% unsecured convertible debentures in the aggregate principal amount of $12,500,000, entitling the holder to acquire 8,620,690 Shares at a conversion price of $1.45 per Share until March 2, 2020;
 
(iii) 4,504,500 common share purchase warrants (the “March Warrants”) (each March Warrant entitles the holder to purchase an additional Share at the price of $1.50 per Share until March 22, 2020;
 
(iv) 2,857,143 common share purchase warrants (the “July Warrants”) (each July Warrant entitles the holder to purchase an additional Share at the price of $0.90 per Share until July 13, 2021);
 
(v) 4,000,000 common share purchase warrants (the “June Warrants”) (each June Warrant entitles the holder to purchase an additional Share at the price of $0.60 per Share until June 28, 2021); and
 
(vi) 101,500 Shares pursuant to securities lending arrangements described in Item 3.6 below, representing approximately 16.74% of the Outstanding Shares, calculated on a partially diluted basis.
 
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse